Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-2 of 2

Sort by

Sort Order Select

Journal Articles

Optimal dosing of vobramitamab duocarmazine, a CD276 (B7-H3) antibody-drug conjugate, leads to durable eradication of Acute Myeloid Leukemia in preclinical xenograft models

Danielle Kirkey, Melia Blankenfeld, Deryk Loo, Isabel Lira, Grace Hawkins, Nika Panahi, Bruce Liu, Rhonda Ries, Jack H. Peplinski, Ezio Bonvini, Stephen Eck, Soheil Meshinchi

Blood (2025) 146 (Supplement 1): 5064.

https://doi.org/10.1182/blood-2025-5064

Published: 2025

Journal Articles

CD276 (B7-H3) Is an Immunotherapeutic Target in Acute Myeloid Leukemia with Preclinical Efficacy of Vobramitamab Duocarmazine, an Investigational CD276 Antibody-Drug Conjugate

Danielle C Kirkey, Melia Blankenfeld, Tiffany Hylkema, Deryk Loo, Ashley Ward, Leila Robinson, Jack H Peplinski, Logan K Wallace, Laura Pardo, Andrew J. Menssen, Rhonda E Ries, Soheil Meshinchi

Blood (2023) 142 (Supplement 1): 5958.

https://doi.org/10.1182/blood-2023-187450

Published: 2023